Similar to what we observed for LABC, MBC, and non-T4 breast cancer patient cases, hormone receptor-positive status was associated with improved BC-SS and OS among IBC patient cases, even after adjustment for HER2 status and other clinically relevant factors (Table 3). The gene discussed is NR4A1; the disease is inflammatory breast carcinoma.